My response to a supposed long over the progress o
Post# of 72447
(Total Views: 628)
Posted On: 08/24/2020 9:42:50 PM
My response to a supposed long over the progress of B as a treatment for CV19 during 2020:
What have you found disappointing? Brilacidin has been moving forward steadily since Feb.
Maybe not as fast as some would prefer, maybe even being held back due to lack of greasing the wheels with lobbyists as the BPs have done, but moving forward nevertheless.
The science is still the same, the results are screaming that B will be a major success in human trials, and after trial results are made known then nothing can hold B back.
Now combine the results of the testing, the success shown on lung issues (COPD,Asthma), kidney issues, brain swelling issues, virus issues, etc and then add the expected results of the human trial in Q4 and 2020 was a BANNER YEAR for both Brilacidin and IPIX. To top it off, we also have succeeded enormously on the financial side. We have about $5-6MM cash still on hand or something like that, we have assured funding from Aspire for being able to handle ourselves any and all trials for other indications we plan on starting, and we should have money starting to flow in from various sources; grants/other countries/private sources wishing to better the world in medical ways.
I personally am quite disturbed by the many longs moaning and groaning now as we are progressing so rapidly beyond what anyone could have imagined for IPIX/Brilacidin at the start of the year it isn't even funny.
So we are looking at something around 8 weeks to get some feedback from human trials IMO.
That should start this juggernaut rolling and I also believe we proceed in Q4 on other indication trials (OM, IBD) and make progress on perfecting and tox testing the Kevetrin pill.
All this with only one actual employee doing everything. Amazing.
What have you found disappointing? Brilacidin has been moving forward steadily since Feb.
Maybe not as fast as some would prefer, maybe even being held back due to lack of greasing the wheels with lobbyists as the BPs have done, but moving forward nevertheless.
The science is still the same, the results are screaming that B will be a major success in human trials, and after trial results are made known then nothing can hold B back.
Now combine the results of the testing, the success shown on lung issues (COPD,Asthma), kidney issues, brain swelling issues, virus issues, etc and then add the expected results of the human trial in Q4 and 2020 was a BANNER YEAR for both Brilacidin and IPIX. To top it off, we also have succeeded enormously on the financial side. We have about $5-6MM cash still on hand or something like that, we have assured funding from Aspire for being able to handle ourselves any and all trials for other indications we plan on starting, and we should have money starting to flow in from various sources; grants/other countries/private sources wishing to better the world in medical ways.
I personally am quite disturbed by the many longs moaning and groaning now as we are progressing so rapidly beyond what anyone could have imagined for IPIX/Brilacidin at the start of the year it isn't even funny.
So we are looking at something around 8 weeks to get some feedback from human trials IMO.
That should start this juggernaut rolling and I also believe we proceed in Q4 on other indication trials (OM, IBD) and make progress on perfecting and tox testing the Kevetrin pill.
All this with only one actual employee doing everything. Amazing.
(10)
(0)